BWV logo

Blue Water Vaccines (BWV) Stock

Profile

Full Name:

Onconetix, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

18 February 2022

Indexes:

Not included

Description:

Blue Water Biotech, Inc., a biotechnology and pharmaceutical company, focuses on developing and commercializing transformational therapies to address health challenges worldwide. The company owns ENTADFI, an FDA-approved, once daily pill that combines finasteride and tadalafil for the treatment of benign prostatic hyperplasia. It is also developing a streptococcus pneumoniae vaccine candidate, which is designed to prevent infectious middle ear infections in children, and prevention of pneumonia in the elderly; and universal flu vaccine that provide protection from all virulent strains in addition to licensing a novel norovirus S&P nanoparticle versatile virus-like particle vaccine platform from Cincinnati Children's to develop vaccines for multiple infectious diseases, including Marburg and monkeypox, and others. The company was formerly known as Blue Water Vaccines, Inc. and changed its name to Blue Water Biotech, Inc. in April 2023. Blue Water Biotech, Inc. was incorporated in 2018 and is headquartered in Cincinnati, Ohio.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Aug 15, 2022

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

13 Sept '23 Maxim Group
Hold
26 Apr '23 HC Wainwright & Co.
Buy
01 Feb '23 HC Wainwright & Co.
Buy
09 Dec '22 HC Wainwright & Co.
Buy
08 Dec '22 Maxim Group
Buy

Screeners with BWV included

No data

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Similar stocks

Blue Water (BWV) Up on Acquisition of 6 FDA-Approved Drugs
Blue Water (BWV) Up on Acquisition of 6 FDA-Approved Drugs
Blue Water (BWV) Up on Acquisition of 6 FDA-Approved Drugs
BWV
Zacks Investment Research15 June 2023

Blue Water (BWV) soars 62% after declaring its deal to purchase six FDA-approved products for $8.5 million. The agreement will help expand the company's portfolio into cardiology and pain management.

Blue Water Biotech to Present Corporate Overview and ENTADFI® Launch Plan at the JMP Securities Life Sciences Conference in New York, NY
Blue Water Biotech to Present Corporate Overview and ENTADFI® Launch Plan at the JMP Securities Life Sciences Conference in New York, NY
Blue Water Biotech to Present Corporate Overview and ENTADFI® Launch Plan at the JMP Securities Life Sciences Conference in New York, NY
BWV
GlobeNewsWire10 May 2023

CINCINNATI, May 10, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (“Blue Water” or the “Company”), a biopharmaceutical company developing transformational therapies to address significant global health challenges, today announced that Blue Water management will present at the JMP Securities Life Sciences Conference at the New York Hilton Midtown on Monday, May 15th at 3:30pm EDT.

FAQ

  • What is the primary business of Blue Water Vaccines?
  • What is the ticker symbol for Blue Water Vaccines?
  • Does Blue Water Vaccines pay dividends?
  • What sector is Blue Water Vaccines in?
  • What industry is Blue Water Vaccines in?
  • What country is Blue Water Vaccines based in?
  • When did Blue Water Vaccines go public?
  • Is Blue Water Vaccines in the S&P 500?
  • Is Blue Water Vaccines in the NASDAQ 100?
  • Is Blue Water Vaccines in the Dow Jones?
  • When was Blue Water Vaccines's last earnings report?
  • When does Blue Water Vaccines report earnings?
  • Should I buy Blue Water Vaccines stock now?

What is the primary business of Blue Water Vaccines?

Blue Water Biotech, Inc., a biotechnology and pharmaceutical company, focuses on developing and commercializing transformational therapies to address health challenges worldwide. The company owns ENTADFI, an FDA-approved, once daily pill that combines finasteride and tadalafil for the treatment of benign prostatic hyperplasia. It is also developing a streptococcus pneumoniae vaccine candidate, which is designed to prevent infectious middle ear infections in children, and prevention of pneumonia in the elderly; and universal flu vaccine that provide protection from all virulent strains in addition to licensing a novel norovirus S&P nanoparticle versatile virus-like particle vaccine platform from Cincinnati Children's to develop vaccines for multiple infectious diseases, including Marburg and monkeypox, and others. The company was formerly known as Blue Water Vaccines, Inc. and changed its name to Blue Water Biotech, Inc. in April 2023. Blue Water Biotech, Inc. was incorporated in 2018 and is headquartered in Cincinnati, Ohio.

What is the ticker symbol for Blue Water Vaccines?

The ticker symbol for Blue Water Vaccines is NASDAQ:BWV

Does Blue Water Vaccines pay dividends?

No, Blue Water Vaccines does not pay dividends

What sector is Blue Water Vaccines in?

Blue Water Vaccines is in the Healthcare sector

What industry is Blue Water Vaccines in?

Blue Water Vaccines is in the Biotechnology industry

What country is Blue Water Vaccines based in?

Blue Water Vaccines is headquartered in United States

When did Blue Water Vaccines go public?

Blue Water Vaccines's initial public offering (IPO) was on 18 February 2022

Is Blue Water Vaccines in the S&P 500?

No, Blue Water Vaccines is not included in the S&P 500 index

Is Blue Water Vaccines in the NASDAQ 100?

No, Blue Water Vaccines is not included in the NASDAQ 100 index

Is Blue Water Vaccines in the Dow Jones?

No, Blue Water Vaccines is not included in the Dow Jones index

When was Blue Water Vaccines's last earnings report?

Blue Water Vaccines's most recent earnings report was on 15 August 2022

When does Blue Water Vaccines report earnings?

The date for Blue Water Vaccines's next earnings report has not been announced yet

Should I buy Blue Water Vaccines stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions